NO20063809L - Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning - Google Patents
Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkningInfo
- Publication number
- NO20063809L NO20063809L NO20063809A NO20063809A NO20063809L NO 20063809 L NO20063809 L NO 20063809L NO 20063809 A NO20063809 A NO 20063809A NO 20063809 A NO20063809 A NO 20063809A NO 20063809 L NO20063809 L NO 20063809L
- Authority
- NO
- Norway
- Prior art keywords
- hydrochloride
- venlaflaxin
- mini tablets
- extended action
- coated mini
- Prior art date
Links
- 239000008185 minitablet Substances 0.000 title abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title 1
- 238000013265 extended release Methods 0.000 abstract 2
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229960002416 venlafaxine hydrochloride Drugs 0.000 abstract 1
- QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN117MU2004 | 2004-02-04 | ||
| IN980MU2004 | 2004-09-13 | ||
| PCT/IN2004/000340 WO2005074895A1 (en) | 2004-02-04 | 2004-10-27 | Extended release coated microtablets of venlafaxine hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20063809L true NO20063809L (no) | 2006-08-25 |
Family
ID=34809925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20063809A NO20063809L (no) | 2004-02-04 | 2006-08-25 | Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7807195B2 (pt) |
| EP (1) | EP1711169B1 (pt) |
| JP (1) | JP2007520547A (pt) |
| KR (1) | KR20070000439A (pt) |
| AT (1) | ATE361743T1 (pt) |
| AU (1) | AU2004315136B2 (pt) |
| BR (1) | BRPI0418283A (pt) |
| CA (1) | CA2555295C (pt) |
| CY (1) | CY1106741T1 (pt) |
| DE (1) | DE602004006443T2 (pt) |
| DK (1) | DK1711169T3 (pt) |
| ES (1) | ES2287813T3 (pt) |
| HR (1) | HRP20070353T3 (pt) |
| IL (1) | IL177243A0 (pt) |
| MX (1) | MXPA06008854A (pt) |
| NO (1) | NO20063809L (pt) |
| NZ (1) | NZ548504A (pt) |
| PL (1) | PL1711169T3 (pt) |
| PT (1) | PT1711169E (pt) |
| RU (1) | RU2340331C2 (pt) |
| SI (1) | SI1711169T1 (pt) |
| UA (1) | UA82597C2 (pt) |
| WO (1) | WO2005074895A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL146462A (en) | 2001-11-13 | 2015-02-26 | Lycored Bio Ltd | Prolonged-release preparations containing as an active compound and analapaxin hydrochloride |
| CA2507685A1 (en) * | 2002-11-28 | 2004-06-10 | Themis Laboratories Private Limited | Process for manufacturing sustained release microbeads containing venlafaxine hci |
| WO2006136927A1 (en) * | 2005-06-22 | 2006-12-28 | Glenmark Pharmaceuticals Limited | Extended release formulations comprising venlafaxine |
| US20080193524A1 (en) * | 2005-07-28 | 2008-08-14 | Dr. Reddy's Laboratories Ltd. | Extended Release Venlafaxine Compositions |
| US20090175934A1 (en) * | 2006-03-08 | 2009-07-09 | Jubilant Organosys Ltd. | Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same |
| WO2007112574A1 (en) * | 2006-04-03 | 2007-10-11 | Isa Odidi | Extended release composition of venlafaxine |
| CN101453996B (zh) * | 2006-04-03 | 2016-05-11 | 伊萨·奥迪迪 | 药物递送组合物 |
| WO2007129329A2 (en) * | 2006-05-08 | 2007-11-15 | Jubilant Organosys Limited | Extended release pharmaceutical formulation comprising venlafaxine hydrochloride |
| AU2007335156A1 (en) * | 2006-12-20 | 2008-06-26 | Mylan Pharmaceuticals Ulc | Pharmaceutical composition comprising a hot-melt granulated lubricant |
| CA2671727C (en) * | 2006-12-20 | 2016-02-16 | Genpharm Ulc | A composition containing a bisphosphonic acid in combination with vitamin d |
| TWI391150B (zh) * | 2008-01-22 | 2013-04-01 | Taiwan Biotech Co Ltd | 腸溶性長效塗覆芯與藥物劑型及其製造方法 |
| CN101756934A (zh) * | 2008-12-10 | 2010-06-30 | 上海复星普适医药科技有限公司 | 文拉法辛缓释制剂的制备方法 |
| KR101787481B1 (ko) | 2010-10-21 | 2017-10-18 | 롯데정밀화학 주식회사 | 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐 |
| CA2826180C (en) | 2011-01-31 | 2020-09-01 | Serotech, Llc | Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder |
| CA3009152C (en) | 2015-12-25 | 2023-08-15 | Toyama Chemical Co., Ltd. | Tablet comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof |
| KR102062052B1 (ko) * | 2018-03-20 | 2020-01-03 | 일양약품주식회사 | 베타네콜 서방성 제제 및 이의 제조방법 |
| KR20230067863A (ko) | 2021-11-10 | 2023-05-17 | 박찬호 | 스마트 계량도구 및 이를 이용한 요리보조 시스템 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4153677A (en) * | 1978-05-18 | 1979-05-08 | Sterling Drug Inc. | Controlled-release composition |
| US4535186A (en) | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
| US6440457B1 (en) | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
| US6274171B1 (en) * | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
| PE57198A1 (es) | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
| UA77145C2 (en) * | 1997-11-05 | 2006-11-15 | Wyeth Corp | Extended release dosage formulation |
| CA2327285C (en) * | 1998-05-15 | 2005-06-14 | Warner-Lambert Company | Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
| KR100748913B1 (ko) | 1999-11-22 | 2007-08-13 | 알자 코포레이션 | 제 1 및 제 2 를 함유하는 삼투성 투약 형태 |
| US6346269B1 (en) * | 2000-05-08 | 2002-02-12 | Standard Chem. & Pharm. Co., Ltd. | Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby |
| US6350471B1 (en) * | 2000-05-31 | 2002-02-26 | Pharma Pass Llc | Tablet comprising a delayed release coating |
| AU2002248792B2 (en) * | 2001-04-18 | 2006-09-21 | Nostrum Pharmaceuticals Inc. | A novel coating for a sustained release pharmaceutical composition |
| US20030091634A1 (en) * | 2001-09-14 | 2003-05-15 | Pawan Seth | Delayed release tablet of venlafaxin |
| CA2470636A1 (en) | 2001-12-20 | 2003-07-03 | Pharmacia Corporation | Zero-order sustained released dosage forms and method of making the same |
| EP1474123A1 (en) * | 2002-01-03 | 2004-11-10 | LEK Pharmaceuticals D.D. | Controlled release pharmaceutical formulation containing venlafaxine |
| AR039164A1 (es) * | 2002-03-28 | 2005-02-09 | Synthon Bv | Sales de venlafaxina de baja solubilidad en agua |
| US20030190352A1 (en) * | 2002-03-28 | 2003-10-09 | Synthon Bv | Compositions of venlafaxine base |
| IL149055A0 (en) * | 2002-04-09 | 2002-11-10 | Karma Pharm Ltd | Extended release composition comprising as active compound venlafaxine hydrochloride |
| CN1674877A (zh) * | 2002-06-07 | 2005-09-28 | 兰贝克赛实验室有限公司 | 控释的多单位药物释放系统 |
| US8216609B2 (en) | 2002-08-05 | 2012-07-10 | Torrent Pharmaceuticals Limited | Modified release composition of highly soluble drugs |
| US7058999B2 (en) * | 2002-10-24 | 2006-06-13 | Paramount Bed Co., Ltd. | Electric bed and control apparatus and control method therefor |
| AU2003274655A1 (en) * | 2002-10-25 | 2004-05-13 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions containing venlafaxine |
| US6703044B1 (en) * | 2002-10-25 | 2004-03-09 | Dexcel Pharma Tech, Ltd | Venlafaxine formulations |
| EP1596837A2 (en) * | 2003-02-07 | 2005-11-23 | Omega Farma Ehf | Sustained release formulations of venlafaxine |
| EP1502587B1 (en) * | 2003-07-30 | 2006-08-23 | Pharmathen S.A. | Sustained release formulation for Venlafaxine hydrochloride |
| US7016014B2 (en) * | 2004-02-27 | 2006-03-21 | Asml Netherlands B.V | Lithographic apparatus and device manufacturing method |
-
2004
- 2004-10-27 DK DK04821278T patent/DK1711169T3/da active
- 2004-10-27 WO PCT/IN2004/000340 patent/WO2005074895A1/en not_active Ceased
- 2004-10-27 DE DE602004006443T patent/DE602004006443T2/de not_active Expired - Fee Related
- 2004-10-27 KR KR1020067014903A patent/KR20070000439A/ko not_active Ceased
- 2004-10-27 MX MXPA06008854A patent/MXPA06008854A/es active IP Right Grant
- 2004-10-27 BR BRPI0418283-9A patent/BRPI0418283A/pt not_active IP Right Cessation
- 2004-10-27 JP JP2006552018A patent/JP2007520547A/ja active Pending
- 2004-10-27 PT PT04821278T patent/PT1711169E/pt unknown
- 2004-10-27 UA UAA200608949A patent/UA82597C2/uk unknown
- 2004-10-27 ES ES04821278T patent/ES2287813T3/es not_active Expired - Lifetime
- 2004-10-27 NZ NZ548504A patent/NZ548504A/en unknown
- 2004-10-27 PL PL04821278T patent/PL1711169T3/pl unknown
- 2004-10-27 CA CA2555295A patent/CA2555295C/en not_active Expired - Fee Related
- 2004-10-27 AU AU2004315136A patent/AU2004315136B2/en not_active Ceased
- 2004-10-27 RU RU2006129034/15A patent/RU2340331C2/ru not_active IP Right Cessation
- 2004-10-27 EP EP04821278A patent/EP1711169B1/en not_active Expired - Lifetime
- 2004-10-27 SI SI200430372T patent/SI1711169T1/sl unknown
- 2004-10-27 HR HR20070353T patent/HRP20070353T3/xx unknown
- 2004-10-27 AT AT04821278T patent/ATE361743T1/de not_active IP Right Cessation
-
2005
- 2005-01-07 US US11/031,266 patent/US7807195B2/en not_active Expired - Fee Related
-
2006
- 2006-08-02 IL IL177243A patent/IL177243A0/en unknown
- 2006-08-25 NO NO20063809A patent/NO20063809L/no not_active Application Discontinuation
-
2007
- 2007-07-19 CY CY20071100959T patent/CY1106741T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06008854A (es) | 2007-01-23 |
| US7807195B2 (en) | 2010-10-05 |
| UA82597C2 (uk) | 2008-04-25 |
| WO2005074895A1 (en) | 2005-08-18 |
| ATE361743T1 (de) | 2007-06-15 |
| PT1711169E (pt) | 2007-07-23 |
| EP1711169B1 (en) | 2007-05-09 |
| HRP20070353T3 (en) | 2008-01-31 |
| BRPI0418283A (pt) | 2007-05-02 |
| RU2006129034A (ru) | 2008-03-10 |
| JP2007520547A (ja) | 2007-07-26 |
| CA2555295A1 (en) | 2005-08-18 |
| EP1711169A1 (en) | 2006-10-18 |
| RU2340331C2 (ru) | 2008-12-10 |
| NZ548504A (en) | 2009-03-31 |
| PL1711169T3 (pl) | 2007-10-31 |
| US20050169985A1 (en) | 2005-08-04 |
| HK1091137A1 (en) | 2007-01-12 |
| DK1711169T3 (da) | 2007-09-17 |
| SI1711169T1 (sl) | 2007-10-31 |
| CA2555295C (en) | 2011-01-18 |
| CY1106741T1 (el) | 2012-05-23 |
| ES2287813T3 (es) | 2007-12-16 |
| DE602004006443T2 (de) | 2008-01-10 |
| KR20070000439A (ko) | 2007-01-02 |
| IL177243A0 (en) | 2006-12-10 |
| DE602004006443D1 (de) | 2007-06-21 |
| AU2004315136B2 (en) | 2010-06-17 |
| AU2004315136A1 (en) | 2005-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063809L (no) | Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning | |
| AR116052A2 (es) | Forma cristalina de clorhidrato de (-)-(1r,2r)-3-(3-dimetilamino-1-etil-2-metilpropil)-fenol | |
| WO2008027557A3 (en) | Topiramate compositions and methods of enhancing its bioavailability | |
| PE20050175A1 (es) | Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad | |
| NO20100250L (no) | Farmasoytisk preparat som innbefatter en S1P reseptoragonist og en sukkeralkohol, og framgangsmate til fremstilling derav | |
| AR049083A1 (es) | Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso | |
| ATE454138T1 (de) | Tablette mit modifizierter freisetzung von bupropion hydrochlorid | |
| NO20081038L (no) | Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering | |
| NO20080827L (no) | Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon | |
| ECSP077999A (es) | Formulaciones de una sal de bupropion de liberación modificada | |
| EA200970267A1 (ru) | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ МНОЖЕСТВО МИНИ-ТАБЛЕТОК, СОДЕРЖАЩИХ ИНГИБИТОР ФАКТОРА Xa | |
| EA200801926A1 (ru) | Таблетки парацетамола с быстрым высвобождением | |
| ECSP045409A (es) | Composiciones y metodos para dosificar liposomas de ciertos tamaños a fin de tratar o prevenir enfermedades. | |
| MY136136A (en) | Pharmaceutical compositions containing terbinafin and use thereof | |
| CY1106693T1 (el) | Πελετες οι οποιες περιεχουν υδροχλωρικη βενλαφαξινη | |
| NO341573B1 (no) | Faste formuleringer av ospemifen og fremgangsmåte for fremstilling av ospemifen | |
| UY25234A1 (es) | Formulación de liberación prolongada de venlafaxina | |
| PE20081106A1 (es) | Comprimidos pediatricos de capecitabina | |
| ES2305567T3 (es) | Formulaciones de tramadol de liberacion sostenida con una eficacia de 24 horas. | |
| PE20080313A1 (es) | Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas | |
| CO6351711A2 (es) | Combinacion de dosis fija en la forma de una tableta de dos copas o de una sola capa de alisquireno y amlodipina | |
| AR039162A1 (es) | Formulaciones de venlafaxina de liberacion extendida | |
| EA200600156A1 (ru) | Пероральная дозировочная форма саквинавирмезилата | |
| UY38028A (es) | Combinación farmacéutica en la forma de comprimidos en bicapa que comprende ketorolaco trometamina y su uso para el tratamiento del dolor | |
| NO20051261L (no) | Morfin-6-glukuronidsalt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |